Andere Sprachen Haisco Pharmaceutical Group Co., Ltd.

Aktien

002653

CNE100001BC7

002653

Pharmazeutika

Schlusskurs Shenzhen S.E. Andere Börsenplätze 20.05.2025			% 5 Tage	% 1. Jan.
43.38 ^CNY	-2.47%		+3.76%	+30.47%

06.05.	Intech Biopharm Ltd. unterzeichnet Zusatzvereinbarung für das Produkt SYN010 mit der Haisco Pharmaceutical Group	CI
24.04.	Haisco Pharmaceutical Group Co erhält einen Vorschlag von Wang Junmin	CI

Andere Sprachen

Haisco Pharmaceutical Group Co., Ltd. Approves A Share Cash Dividend for the Year 2024, Payable on 15 May 2025	07.05.
Intech Biopharm Ltd. Signs Supplemental Agreement for the SYN010 Product with Haisco Pharmaceutical Group	06.05.
Haisco Pharmaceutical Group Co Receives a Proposal from Wang Junmin	24.04.
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	24.04.
Haisco Pharmaceutical Group Co., Ltd. Proposes Final Cash Dividend for the Year 2024	14.04.
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	11.04.
Haisco Pharmaceutical Group Clarifies No Financial Assistance in Share Issuance	03.03.
Haisco Pharmaceutical Group Co., Ltd. announced that it expects to receive CNY 1.3652567 billion in funding	27.02.
Haisco Pharma's Unit Gets Nod to Trial HSK39004 Inhalation Powder	06.02.
Haisco Pharma Plans To Set Up Subsidiary In U.S. For Business Development	06.02.
Chinese Drug Regulator Accepts Haisco Pharma Unit's Application for Advanced Tumor Drug	17.01.
Haisco Pharmaceutical Group Co., Ltd. Approves Profit Distribution Plan for Third Quarter 2024, Payable on 24 January 2025	16.01.
Declaration of Voting Results by Haisco Pharmaceutica	15.01.
Haisco Pharmaceutica Receives a Shareholder Proposal from Wang Junmin	05.01.
Haisco Pharmaceutical Group Co., Ltd. Proposes Dividend for Third Quarter of 2024	31.12.
Haisco Pharmaceutical, Unit Get Government Grants of 44 Million Yuan	19.12.
Haisco Pharmaceutical Group Unit Gets Chinese Regulator's Nod for Prostrate Cancer Drug Clinical Trials	05.12.
Haisco Pharmaceutical Group Sees Inclusion of Two Drugs in National Medical Insurance Catalog	29.11.
Haisco Pharmaceutical Gets China Nod for Respiratory Drug	07.11.
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	29.10.24
Haisco Pharmaceutical to Set Up Subsidiaries in British Virgin Islands, Cayman Islands	20.09.24
Haisco Pharmaceutical Group Co., Ltd. Announces Interim Cash Dividend on A Shares for the Year 2024, Payable on 18 September 2024	09.09.24
Haisco Pharmaceutical Group Co., Ltd. Interim Cash Dividend for 2024	06.09.24
Haisco Pharmaceutical Group Co., Ltd. Proposes Interim Dividend for the First Half of 2024	16.08.24
Haisco Pharmaceutical Group H1 Profit More than Doubles, Operating income Rises 23%	16.08.24

Keine Ergebnisse zu dieser Suche

Mehr Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Haisco Pharmaceutical Group Co., Ltd.

Aktien

002653

CNE100001BC7

002653

Pharmazeutika

Andere Sprachen

Filter